Maximising global efficiencies, by David Hunt
I’m incredibly fortunate to travel the world doing a job that I love. Five years ago it was the likes of Barcelona, Geneva & Milan, as I covered Europe. Today it is both the Northern & Southern Hemispheres, East & West. Typically we deliver academies & build expertise in social media, closed-loop marketing & integrated communications. My first day back to work in 2014 was in Osaka, being simultaneously translated as we discussed transforming field force interactions. (It is a really quite mind-boggling scenario when you stop to think.)
Beyond seeing the sights & sampling the local cuisine the different cultures, inside & outside the office, are fascinating. The insight it provides to shape global campaigns is invaluable.
The pharma industry is obsessed, rightly so, by closed-loop marketing. We believe in the value of personalised stories. At the same time we chase an increasingly global approach to communications. It’s a striking contradiction in policies. It represents an awkward balance of broad & narrow brush. It is also one I agree with, largely. But, I do think it lacks a subtlety. Are we one global community, a single market, the same the world over? Because on the surface, driven by geography, politics, religion we appear incredibly different. A campaign conceived in the US will not work in China. A Japanese campaign would be dismissed in Europe. South America emerged as the victors from Cannes Health Lions, but their ideas would be lost on some.
We certainly don’t need local campaigns and the necessary investment would be foolish. Cultural campaigns, however, would be an interesting concept, aligned through a consistent scientific story, that marries clinical data & patient benefits. Representing efficiencies & relevance, the solution would allow local markets to provide context, relevance & individual customer experiences.
I’ve learnt a huge amount on my travels, the most significant being humility & respect.